Doctors described it as "ingenious" and were impressed by its effectiveness. They also highlighted the importance of its availability to patients through Apotek1, emphasizing the added convenience and accessibility for those in need of a reliable solution for managing nosebleeds. The positive feedback from healthcare providers reinforces the product's value in the clinical setting.
Positive Reception for NosePlug at ENT Exhibition in Oslo, 24-26 October
At an ENT exhibition in Oslo, medical professionals expressed high praise for the NosePlug, a product designed to treat epistaxis (nosebleeds).
Similar Posts
Hogne Showcasing the Noseplug at Drug Delivery Summit 2024
Hogne is thrilled to announce its participation in the Drug Delivery Summit 2024, taking place in San Diego, California, USA, on February 3–4, 2025.
Medicamässan in Düsseldorf: Strong Interest in NosePlug Innovation
From November 11th to 13th, Medica in Düsseldorf provided an exciting platform to showcase the innovative NosePlug.
Hogne presents the NosePlug® at Sweden's most significant ear, nose and throat scientific congress
The ENT Days is Sweden's most significant scientific congress on ear, nose, and throat diseases, as well as head and neck surgery. This year's event took place from September 17-20 in Umeå and featured a top-tier scientific program.